Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EIF4EBP1 | Q13541 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL29885546 | 1.00 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| Water SCHEMBL27165018 | 1.00 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| SCHEMBL29661934 | 1.00 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| SCHEMBL24070616 | 0.94 | EIF4EBP1 (0.89) | EIF4EBP1 | |
| SCHEMBL31668364 | 0.94 | EIF4EBP1 (0.89) | EIF4EBP1 | |
| SCHEMBL29650414 | 0.93 | EIF4EBP1 (0.86) | EIF4EBP1 | |
| SCHEMBL22866517 | 0.93 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| SCHEMBL29650574 | 0.93 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| SCHEMBL31668389 | 0.89 | EIF4EBP1 (0.85) | EIF4EBP1 | |
| SCHEMBL31668380 | 0.89 | EIF4EBP1 (0.85) | EIF4EBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240076301-A1 | Solid Forms of an eIF4E Inhibitor | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2024-03-07 | — | — | US | disclosed |
| WO-2021003157-A1 | EIF4E-INHIBITING 4-OXO-3,4-DIHYDROPYRIDO[3,4-D]PYRIMIDINE COMPOUNDS | EFFECTOR THERAPEUTICS, INC. (US) | 2021-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240076301-A1 | Solid Forms of an eIF4E Inhibitor | EIF4E, EIF4EBP1, EIF4A1 | EIF4EBP1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.